Presentation THT 2026 Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction Presenter: Thitiphan Srikulmontri March 03, 2026
Presentation THT 2026 Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients Presenter: Sandip K. Zalawadiya March 03, 2026
Presentation THT 2026 Comprehensive clinical benefit of CCM in HFrEF patients – a win-ratio analysis of FIX-HF-5C randomized trial Presenter: Rami Kahwash March 03, 2026
Presentation THT 2026 Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction Presenter: Stephen Wildhirt March 03, 2026
Presentation THT 2026 Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction Presenter: Edwin Ho March 03, 2026
Presentation THT 2026 Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial Presenter: Sanjiv J. Shah March 03, 2026
Presentation THT 2026 Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results Presenter: Benjamin Hibbert March 03, 2026
Presentation THT 2026 Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction Presenter: Afek Kodesh March 03, 2026
Presentation THT Abstracts 2026 From Pressure Data to Clinical Impact: CardioMEMS in Heart Failure with Preserved Ejection Fraction Management Presenter: Gabriella Bayshtok March 02, 2026
Presentation THT 2026 Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45% Presenter: Rami Kahwash March 02, 2026
Presentation THT Abstracts 2026 Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study Presenter: Philipp von Stein March 02, 2026
Presentation THT Abstracts 2026 Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction Presenter: Nishanth Katukuri March 02, 2026
Presentation THT 2026 Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report Presenter: David Niehaus March 02, 2026
News Features Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts Michael O'Riordan February 24, 2026
News Conference News EAPCI 2026 EAPCI Summit 2026: What to Expect in Munich Caitlin E. Cox February 11, 2026
News Daily News Q&A: Lior Jankelson on AI Tools for Suspected ACS and More Todd Neale February 10, 2026
News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant Michael O'Riordan January 28, 2026